FRO – Q2 2025 Presentation Please find enclosed the presentation of Frontline plc´s second quarter 2025 results to be held on the webcast / conference call 29 August, 2025 at 15:00 CET. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment
FRO – Second Quarter and Six Months 2025 Results FRONTLINE PLC REPORTS RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025 Frontline plc (the “Company”, “Frontline,” “we,” “us,” or “our”), today reported unaudited results for the six months ended June 30, 2025: Highlights Profit of $77.5 million, or $0.35 per share for the second quarter of 2025.Adjusted profit of $80.4 million, or $0.36 per share for the second quarter of 2025.Declared a cash dividend of $0.36 per share for the second quarter of 2025.Reported revenues of $480.1 million for the second quarter of 2025.Achieved average dail...
FRO – Invitation to Q2 2025 Results Conference Call and Webcast Frontline plc.’s preliminary second quarter 2025 results will be released on Friday August 29, 2025, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at ahead of the conference call. In order to attend the conference call you may do one of the following: a. WebcastGo to the Investor Relations section at and follow the “Webcast” link, or access directly from the link below. b. Conferenc...
A director at Novo Nordisk AS bought 2,350 shares at 349.044DKK and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
A director at NRC Group ASA bought 120,000 shares at 6.000NOK and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.